PYXS

Conviction 63HealthcareScan · Mon, Aug 10, 2026

PYXS$3.82+2.41%

ResistanceSupportVol 14

Vol MA14 1.19M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Pyxis Oncology, Inc.PHARMACEUTICAL PREPARATIONSwww.pyxisoncology.com ↗

Price3.82

Change+2.41%

Gap+2.55%

Rel volume0.70×

Avg volume985.42K

Avg $ vol2.84M

SMA 202.83

SMA 502.43

SMA 2002.34

Price vs 50+57.05%

Price vs 200+63.42%

MA stackbullish

50/200 crossgolden · 2d

Supertrendup · 2.94

RSI (14)72

MACD hist0.11

MACD cross—

Stoch %K / %D91 / 94

ADX (14)39

+DI / −DI38 / 9

RSI divergence—

MACD divergence—

ATR %+7.86%

ADR %9.39%

52w high5.34

52w low1.04

From 52w high-28.46%

Above 52w low+267.31%

New 52w highNo

SqueezeOff

Bollinger width69.54%

%B1.01

Donchian pos91.37%

Donchian high3.98

Donchian low2.13

AVWAP (52w high)2.13

vs AVWAP high+79.14%

AVWAP (52w low)2.33

vs AVWAP low+64.13%

OBV trendUp

Chaikin MF (20)0.14

Today vs 20d0.70×

Avg vol (14d)1.19M

Avg vol (20d)985.42K

Avg $ vol (20d)2.84M

Market cap242.02M

RS 3m (vs SPY)+59.35%

RS 6m (vs SPY)+128.09%

RS line new highNo

Trend template4/8

Technical rank97.0

1 week+25.66%

1 month+43.07%

3 months+39.42%

6 months+152.98%

1 year+257.01%

YTD+232.17%

P/E-3.04

P/B7.74

P/S17.46

P/FCF-3.81

EPS-1.28

Div yield—

ROE-254.64%

ROA-123.83%

Debt/Eq—

Current2.76

EV/EBITDA-2.96

Gross margin—

Net margin-574.55%

Rev growth-14.17%

EPS growth-2.96%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value236.25M

Revenue2.82M

Net income-23.27M

Gross profit—

Free cash flow-63.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out63.36M

Employees56

ListedFri, Oct 8, 2021

Free float41.37M

Float %66.5%

Short interest3.25M

Days to cover3.1d

Short volume50.5%

Squeeze score38 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction63 / 100

Pattern quality—

Tech rank97.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.30

Support1.89

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PYXS

All disclosures →

No recent disclosed trades by Congress in PYXS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PYXS

No recent insider (Form 4) filings in PYXS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PYXS · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.